H-TPNQRQNVC-OH
Ref. 3D-PP47917
| 1mg | 217.00 € | ||
| 10mg | 253.00 € | ||
| 100mg | 455.00 € |
Product Information
Peptide H-TPNQRQNVC-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-TPNQRQNVC-OH include the following: Myeloid leukemic progenitor cells can be specifically targeted by minor histocompatibility antigen LRH-1-reactive cytotoxic T cells WJ Norde, IM Overes, F Maas, H Fredrix - Blood, The Journal , 2009 - ashpublications.orghttps://ashpublications.org/blood/article-abstract/113/10/2312/24355 4 PD WJ Norde, F Maas, W Hobo, A Korman - strategies after stem cell , 2013 - Citeseerhttps://citeseerx.ist.psu.edu/document?repid=rep1&type=pdf&doi=84902d132325b987f60cba6224467a548cad0913#page=45 PD-1/PD-L1 interactions contribute to functional T-cell impairment in patients who relapse with cancer after allogeneic stem cell transplantation WJ Norde, F Maas, W Hobo, A Korman, M Quigley - Cancer research, 2011 - AACRhttps://aacrjournals.org/cancerres/article-abstract/71/15/5111/568065 7 Improving dendritic cell vaccine immunogenicity by silencing PD W Hobo, TI Novobrantseva, H Fredrix - strategies after stem , 2013 - repository.ubn.ru.nlhttps://repository.ubn.ru.nl/bitstream/handle/2066/106929/106929.pdf#page=83 Improving dendritic cell vaccine immunogenicity by silencing PD-1 ligands using siRNA-lipid nanoparticles combined with antigen mRNA electroporation W Hobo, TI Novobrantseva, H Fredrix, J Wong - Cancer Immunology , 2013 - Springerhttps://link.springer.com/article/10.1007/s00262-012-1334-1 siRNA silencing of PD-L1 and PD-L2 on dendritic cells augments expansion and function of minor histocompatibility antigen-specific CD8+ T cells W Hobo, F Maas, N Adisty, T de Witte - Blood, The Journal , 2010 - ashpublications.orghttps://ashpublications.org/blood/article-abstract/116/22/4501/107827 6 siRNA silencing of PD-L1 and PD-L2 on dendritic cells augments expansion and function of minor histocompatibility antigen-specific CD8 W Hobo, F Maas, N Adisty, T de Witte - strategies after stem , 2013 - repository.ubn.ru.nlhttps://repository.ubn.ru.nl/bitstream/handle/2066/106929/106929.pdf?sequence=1#page=70 The Aryl Hydrocarbon Receptor Antagonist StemRegenin 1 Promotes Human Plasmacytoid and Myeloid Dendritic Cell Development from CD34+ Hematopoietic S Thordardottir, BN Hangalapura, T Hutten - Stem cells and , 2014 - liebertpub.comhttps://www.liebertpub.com/doi/abs/10.1089/scd.2013.0521 StemRegenin S Thordardottir, BN Hangalapura, T Hutten, M Cossu - smadpathway.comhttps://smadpathway.com/stemregenin-1/ Clinically applicable CD34+-derived blood dendritic cell subsets exhibit key subset-specific features and potently boost anti-tumor T and NK cell responses J van Eck van der Sluijs, D van Ens - Cancer Immunology , 2021 - Springerhttps://link.springer.com/article/10.1007/s00262-021-02899-3 Aberrant expression of the hematopoietic-restricted minor histocompatibility antigen LRH-1 on solid tumors results in efficient cytotoxic T cell-mediated lysis IM Overes, T Henriaca«tte Levenga, JCM Vos - Cancer immunology , 2009 - Springerhttps://link.springer.com/article/10.1007/s00262-008-0569-3 Efficient activation of LRH-1-specific CD8+ T-cell responses from transplanted leukemia patients by stimulation with P2X5 mRNA-electroporated dendritic cells IM Overes, H Fredrix, MGD Kester - Journal of , 2009 - journals.lww.comhttps://journals.lww.com/immunotherapy-journal/fulltext/2009/07000/A_Novel_Flow_Cytometric_Assay_for_Evaluating.1.aspx PD-L1 siRNA-mediated silencing in acute myeloid leukemia enhances anti-leukemic T cell reactivity CM Mousset, D van Ens , TJA Hutten - Improvement of T cell , 2019 - core.ac.ukhttps://core.ac.uk/download/pdf/231968075.pdf#page=130 Minor histocompatibility antigen-specific T cells C Summers, VS Sheth, M Bleakley - Frontiers in Pediatrics, 2020 - frontiersin.orghttps://www.frontiersin.org/articles/10.3389/fped.2020.00284/full A frameshift polymorphism in P2X5 elicits an allogeneic cytotoxic T lymphocyte response associated with remission of chronic myeloid leukemia B de Rijke, A van Horssen-Zoetbrood - The Journal of , 2005 - Am Soc Clin Investighttps://www.jci.org/articles/view/24832
Chemical properties
Technical inquiry about: 3D-PP47917 H-TPNQRQNVC-OH
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
